Benefits
Muscle protein synthesis and recovery acceleration
In an independent trial, the peptide network raised muscle protein synthesis rates during recovery from limb immobilization, and a manufacturer-funded trial reported faster strength recovery and reduced fatigue after damaging exercise. The peptides activate the mTORC1 pathway and lower plasma myostatin. The recovery effects are modest and the trials are small, so this is promising rather than established.
Strength and muscle performance
Two manufacturer-funded randomized trials reported improved strength recovery and greater leg-strength gains with resistance training versus placebo. The independent trial, by contrast, found the peptide no better than milk protein for preserving muscle size. The positive strength findings are modest, come from small trials, and have not been independently replicated.
Protein utilization (not directly measured)
An independent trial found higher muscle protein synthesis rates during recovery from immobilization with the peptide than with milk protein. Claims that it lets the body extract more muscle-building value from ordinary protein intake go beyond what has been directly measured, and a separate trial of whole fava bean protein found no increase in muscle protein synthesis.
Muscular endurance
One manufacturer-funded trial (72 adults, 56 days of resistance training) reported greater muscular endurance, measured as repetitions to exhaustion, versus placebo. This is resistance-exercise endurance rather than aerobic capacity, the trial was funded by the maker, and the finding has not been independently replicated.
Mechanism of action
AI-identified peptide mTORC1 activation and myostatin inhibition
Nuritas' Magnifier AI platform analyzed thousands of fava bean protein sequences against proteomics databases to identify peptide sequences with predicted mTORC1 activating and myostatin-binding properties. The identified peptides activate mTORC1/p70S6K signaling (triggering muscle protein synthesis initiation) while simultaneously binding and partially blocking myostatin — the TGF-β family member that limits muscle growth. This dual mechanism is proposed to support the anabolic response to exercise, but it has not been tested head to head against leucine or EAA supplementation in people.
Clinical trials
Randomized, double-blind, placebo-controlled trial of PeptiStrong® (2,400 mg/day fava bean peptides) effects on recovery from exercise-induced muscle damage. Outcomes: CK, range of motion, strength recovery. (Kerr 2023, Nutrients)
Trained adults post-exercise.
PeptiStrong® accelerated recovery from exercise-induced muscle damage, reduced CK elevation, improved range of motion vs placebo. Industry-funded (Nuritas). Effect sizes modest. Note: PeptiStrong® was 'discovered' using AI-driven peptide screening from fava beans — novel discovery approach.
Independent randomized controlled trial (Maastricht University) in 30 young men comparing the fava bean peptide network (NPN_1/PeptiStrong, 10 g twice daily) with milk protein during 7 days of leg immobilization and 14 days of remobilization. Outcomes: quadriceps size and muscle protein synthesis. (2023, J Nutr)
Active adults.
The peptide network did not differ from milk protein for the primary outcome, quadriceps size, during immobilization or remobilization. Muscle protein synthesis rates during remobilization were higher with the peptide than with milk protein (a secondary outcome). This is non-inferiority to ordinary protein, not superiority. A separate trial of whole fava bean protein found no rise in muscle protein synthesis. Whey and milk protein have decades of stronger evidence.